By Philip Stevens, Executive Director, Geneva Network Republished with permission of the Geneva Network. Original available here. The patent-based system of drug development comes under further pressure from key countries aiming to increase access to medicines at a joint World Health Organization and Government of India meeting in New Delhi this week. […]
Tag: drug pricing
In The Middle Of It: U.S. Scrutinizes Pharma Benefits Managers
In case anyone was wondering, it’s never good to be identified as a “middleman.” That’s the label being applied to pharmacy benefits managers who are being blamed for jacking up pharmaceutical prices through opaque agreements with pharmaceutical manufacturers and insurers, which allow the PBMs to negotiate substantial discounts without passing the savings along to […]